rs3216174

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP6BA1

The NM_001360016.2(G6PD):​c.486-34delT variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00354 in 1,205,636 control chromosomes in the GnomAD database, including 130 homozygotes. There are 1,325 hemizygotes in GnomAD. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0035 ( 12 hom., 148 hem., cov: 23)
Exomes 𝑓: 0.0035 ( 118 hom. 1177 hem. )

Consequence

G6PD
NM_001360016.2 intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: -0.169

Publications

6 publications found
Variant links:
Genes affected
G6PD (HGNC:4057): (glucose-6-phosphate dehydrogenase) This gene encodes glucose-6-phosphate dehydrogenase. This protein is a cytosolic enzyme encoded by a housekeeping X-linked gene whose main function is to produce NADPH, a key electron donor in the defense against oxidizing agents and in reductive biosynthetic reactions. G6PD is remarkable for its genetic diversity. Many variants of G6PD, mostly produced from missense mutations, have been described with wide ranging levels of enzyme activity and associated clinical symptoms. G6PD deficiency may cause neonatal jaundice, acute hemolysis, or severe chronic non-spherocytic hemolytic anemia. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
G6PD Gene-Disease associations (from GenCC):
  • anemia, nonspherocytic hemolytic, due to G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • G6PD deficiency
    Inheritance: XL Classification: DEFINITIVE Submitted by: ClinGen
  • class I glucose-6-phosphate dehydrogenase deficiency
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP6
Variant X-154534529-GA-G is Benign according to our data. Variant chrX-154534529-GA-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 439744.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.0767 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
G6PDNM_001360016.2 linkc.486-34delT intron_variant Intron 5 of 12 ENST00000393562.10 NP_001346945.1
G6PDNM_000402.4 linkc.576-34delT intron_variant Intron 5 of 12 NP_000393.4 P11413-3
G6PDNM_001042351.3 linkc.486-34delT intron_variant Intron 5 of 12 NP_001035810.1 P11413-1A0A384NL00

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
G6PDENST00000393562.10 linkc.486-34delT intron_variant Intron 5 of 12 1 NM_001360016.2 ENSP00000377192.3 P11413-1

Frequencies

GnomAD3 genomes
AF:
0.00355
AC:
398
AN:
112098
Hom.:
12
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000649
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0852
Gnomad SAS
AF:
0.00146
Gnomad FIN
AF:
0.0119
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000283
Gnomad OTH
AF:
0.00198
GnomAD2 exomes
AF:
0.00889
AC:
1586
AN:
178413
AF XY:
0.00758
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000256
Gnomad ASJ exome
AF:
0.000403
Gnomad EAS exome
AF:
0.0950
Gnomad FIN exome
AF:
0.0102
Gnomad NFE exome
AF:
0.00113
Gnomad OTH exome
AF:
0.00447
GnomAD4 exome
AF:
0.00354
AC:
3866
AN:
1093484
Hom.:
118
Cov.:
32
AF XY:
0.00327
AC XY:
1177
AN XY:
360014
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26356
American (AMR)
AF:
0.000284
AC:
10
AN:
35186
Ashkenazi Jewish (ASJ)
AF:
0.000258
AC:
5
AN:
19367
East Asian (EAS)
AF:
0.0964
AC:
2909
AN:
30189
South Asian (SAS)
AF:
0.000999
AC:
54
AN:
54051
European-Finnish (FIN)
AF:
0.0123
AC:
462
AN:
37654
Middle Eastern (MID)
AF:
0.000732
AC:
3
AN:
4097
European-Non Finnish (NFE)
AF:
0.000241
AC:
203
AN:
840607
Other (OTH)
AF:
0.00479
AC:
220
AN:
45977
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
148
296
443
591
739
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
52
104
156
208
260
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00353
AC:
396
AN:
112152
Hom.:
12
Cov.:
23
AF XY:
0.00431
AC XY:
148
AN XY:
34344
show subpopulations
African (AFR)
AF:
0.0000647
AC:
2
AN:
30908
American (AMR)
AF:
0.00
AC:
0
AN:
10712
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2649
East Asian (EAS)
AF:
0.0846
AC:
297
AN:
3510
South Asian (SAS)
AF:
0.00146
AC:
4
AN:
2732
European-Finnish (FIN)
AF:
0.0119
AC:
74
AN:
6207
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
219
European-Non Finnish (NFE)
AF:
0.000283
AC:
15
AN:
53000
Other (OTH)
AF:
0.00261
AC:
4
AN:
1534
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
13
26
40
53
66
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00127
Hom.:
9
Bravo
AF:
0.00418
Asia WGS
AF:
0.0290
AC:
72
AN:
2522

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Anemia, nonspherocytic hemolytic, due to G6PD deficiency Uncertain:1Benign:1
Aug 12, 2022
Dunham Lab, University of Washington
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:curation

Variant found in unrelated hemizygotes with deficiency (PS4_M, PP4). Decreased activity in red blood cells (PS3). Reported as benign by multiple clinical testing groups (BP6). Post_P 0.89997 (odds of pathogenicity 80.97, Prior_P 0.1). -

Jan 31, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Jan 20, 2017
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
Jul 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 30077011, 26829728) -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
-0.17
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.080
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3216174; hg19: chrX-153762744; COSMIC: COSV107472158; COSMIC: COSV107472158; API